Evidence map›Paper›PMID 34595454›Full record

ReviewClinical hematology international2020

Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?

Anna Suska, David H Vesole, Jorge J Castillo, Shaji K Kumar, Hari Parameswaran, Maria V Mateos, Thierry Facon, Alessandro Gozzetti, Gabor Mikala, Marta Szostek and 4 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical hematology international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 7 countries.

Anna SuskaDepartment of Hematology, Jagiellonian University Medical College, Kopernika 17, Krakow 31-501, Poland.
David H VesoleThe John Theurer Cancer Center at Hackensack UMC, Hackensack, NJ, USA.
Jorge J CastilloDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Shaji K KumarDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Hari ParameswaranMedical College of Wisconsin, Milwaukee, WI, USA.
Maria V MateosComplejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (CAUSA/IBSAL), Salamanca, Spain.
Thierry FaconService des Maladies du Sang, Hôpital Claude Huriez, Lille, France.
Alessandro GozzettiDivision of Hematology and Transplants, University of Siena, Siena, Italy.
Gabor MikalaDepartment of Hematology and Stem Cell Transplantation, South-Pest Central Hospital, Natl. Inst. Hematol. Infectol, Budapest, Hungary.
Marta SzostekDepartment of Hematology, Jagiellonian University Medical College, Kopernika 17, Krakow 31-501, Poland.
Joseph MikhaelTranslational Genomics Research Institute, City of Hope Cancer Center, Phoenix, Arizona, USA.
Roman HajekUniversity Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Evangelos TerposDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Artur JurczyszynDepartment of Hematology, Jagiellonian University Medical College, Kopernika 17, Krakow 31-501, Poland.
Jagiellonian University · PLComplejo Hospitalario de Salamanca · ESHackensack University Medical Center · USHarvard University · USHôpital Claude Huriez · FRMayo Clinic in Arizona · USMedical College of Wisconsin · USNational and Kapodistrian University of Athens · GRTranslational Genomics Research Institute · USUniversity Hospital Ostrava · CZUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma cell leukemia (PCL) is an aggressive hematological malignancy characterized by an uncontrolled clonal proliferation of plasma cells (PCs) in the bone marrow and peripheral blood. PCL has been defined by an absolute number of circulating PCs exceeding 2.0 × 10

Indexed as

chemotherapyclinical trialsnovel agentsplasma cell dyscrasiaPlasma cell leukemiaprognostic indexstem cell transplantation

Identifiers

PMID34595454
PMCPMC8432408
OpenAlexW3042630715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.